Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy and safety of pramipexole in restless legs syndrome.

Literature DB >> 17618531

Efficacy and safety of pramipexole in restless legs syndrome.

John C Morgan, Kapil D Sethi.

Abstract

Entities: Chemical Disease

Year: 2007 PMID： 17618531

Source DB: PubMed Journal: Curr Neurol Neurosci Rep ISSN： 1528-4042 Impact factor: 5.081

× No keyword cloud information.

26 in total

1. Ropinirole versus placebo in primary restless legs syndrome.

Authors: John C Morgan; Kapil D Sethi
Journal: Curr Neurol Neurosci Rep Date: 2006-07 Impact factor: 5.081

2. Valvular heart disease and the use of dopamine agonists for Parkinson's disease.

Authors: Renzo Zanettini; Angelo Antonini; Gemma Gatto; Rosa Gentile; Silvana Tesei; Gianni Pezzoli
Journal: N Engl J Med Date: 2007-01-04 Impact factor: 91.245

3. Zonisamide has beneficial effects on Parkinson's disease patients.

Authors: M Murata; E Horiuchi; I Kanazawa
Journal: Neurosci Res Date: 2001-12 Impact factor: 3.304

Review 4. Insight into the pathophysiology of restless legs syndrome.

Authors: C J Earley; R P Allen; J L Beard; J R Connor
Journal: J Neurosci Res Date: 2000-12-01 Impact factor: 4.164

5. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.

Authors: Theresa A Zesiewicz; Christopher L Ward; Robert A Hauser; Juan Sanchez-Ramos; Joseph F Staffetti; Kelly L Sullivan
Journal: Mov Disord Date: 2007-01-15 Impact factor: 10.338

6. Treatment of restless legs syndrome with levodopa plus benserazide.

Authors: S Akpinar
Journal: Arch Neurol Date: 1982-11

7. An algorithm for the management of restless legs syndrome.

Authors: Michael H Silber; Bruce L Ehrenberg; Richard P Allen; Mark J Buchfuhrer; Christopher J Earley; Wayne A Hening; David B Rye
Journal: Mayo Clin Proc Date: 2004-07 Impact factor: 7.616

8. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.

Authors: Arthur S Walters; William G Ondo; Tilman Dreykluft; Ron Grunstein; Daniel Lee; Kapil Sethi
Journal: Mov Disord Date: 2004-12 Impact factor: 10.338

Efficacy and safety of pramipexole in restless legs syndrome.

1. Ropinirole versus placebo in primary restless legs syndrome.

2. Valvular heart disease and the use of dopamine agonists for Parkinson's disease.

3. Zonisamide has beneficial effects on Parkinson's disease patients.

Review 4. Insight into the pathophysiology of restless legs syndrome.

5. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.

6. Treatment of restless legs syndrome with levodopa plus benserazide.

7. An algorithm for the management of restless legs syndrome.

8. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.

9. Treatment of the restless legs syndrome with carbamazepine: a double blind study.

10. Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.

1. Actigraph evaluation of acupuncture for treating restless legs syndrome.

2. Acupuncture and related techniques for restless legs syndrome: A protocol for systematic review and meta-analysis.